ENT Surgical Oncology Section, Hospital Clínic, Barcelona, Spain.
Head Neck. 2011 Sep;33(9):1252-9. doi: 10.1002/hed.21605. Epub 2010 Oct 27.
To evaluate the outcomes of transoral laser microsurgery (TLM) in the treatment of T2 to T3 laryngeal carcinomas growing in the laryngeal anterior commissure.
This study was a retrospective analysis of 107 patients. Overall survival, disease-specific survival, and laryngectomy-free survival were analyzed. Technical difficulties, postoperative complications, influence of the learning curve, and the number of surgeries were evaluated.
Five-year overall survival, disease-specific survival, and laryngectomy-free survival were 71%, 79.5%, and 71.4%, respectively. The probability of tumor relapse was related to the status of the margins (p = .01) and to surgical experience (p = .02), but not to tumor exposure (p = .78) or pT category (p = .36). Disease-specific survival differed significantly between the group of patients treated in the early period of surgical experience and those treated in the advanced period of surgical experience (71% vs 94%; p = .02)
TLM is a useful treatment for T2 to T3 laryngeal carcinomas growing in the laryngeal anterior commissure when it is performed under an advanced learning curve.
评估经口激光显微手术(TLM)治疗前联合生长的 T2 至 T3 声门型喉癌的疗效。
这是一项回顾性分析,共纳入 107 例患者。分析了总生存率、疾病特异性生存率和喉切除术无生存率。评估了技术难度、术后并发症、学习曲线的影响以及手术次数。
5 年总生存率、疾病特异性生存率和喉切除术无生存率分别为 71%、79.5%和 71.4%。肿瘤复发的概率与切缘状态(p =.01)和手术经验(p =.02)相关,而与肿瘤暴露(p =.78)或 pT 类别(p =.36)无关。在手术经验的早期和晚期治疗的患者之间,疾病特异性生存率有显著差异(71% vs 94%;p =.02)。
当在高级学习曲线下进行时,TLM 是治疗前联合生长的 T2 至 T3 声门型喉癌的有效方法。